Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin M Collman

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Drug Development and Industrial Pharmacy|March 3, 2012
Comparison of a rational vs. high throughput approach for rapid salt screening and selectionBenjamin M Collman, Jonathan M Miller, Christopher Seadeek, et al.
Pharmaceutical Development and Technology|June 2, 2005
Identifying the stable polymorph early in the drug discovery-development processJonathan M Miller, Benjamin M Collman, Landon R Greene, et al.
Journal of Pharmaceutical Sciences|September 21, 2007
Stable-form screening: overcoming trace impurities that inhibit solution-mediated phase transformation to the stable polymorph of sulfamerazineYuchuan Gong, Benjamin M Collman, Shawn M Mehrens, et al.
Journal of Medicinal Chemistry|April 1, 2011
Discovery of a clinical candidate from the structurally unique dioxa-bicyclo[3.2.1]octane class of sodium-dependent glucose cotransporter 2 inhibitorsVincent Mascitti, Tristan S Maurer, Ralph P Robinson, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Drug Development and Industrial Pharmacy|March 3, 2012
Comparison of a rational vs. high throughput approach for rapid salt screening and selectionBenjamin M Collman, Jonathan M Miller, Christopher Seadeek, et al.
Pharmaceutical Development and Technology|June 2, 2005
Identifying the stable polymorph early in the drug discovery-development processJonathan M Miller, Benjamin M Collman, Landon R Greene, et al.
Journal of Pharmaceutical Sciences|September 21, 2007
Stable-form screening: overcoming trace impurities that inhibit solution-mediated phase transformation to the stable polymorph of sulfamerazineYuchuan Gong, Benjamin M Collman, Shawn M Mehrens, et al.
Journal of Medicinal Chemistry|April 1, 2011
Discovery of a clinical candidate from the structurally unique dioxa-bicyclo[3.2.1]octane class of sodium-dependent glucose cotransporter 2 inhibitorsVincent Mascitti, Tristan S Maurer, Ralph P Robinson, et al.
Pageof 1